The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.

Metastasis is responsible for the majority of cancer associated fatalities. Tumor cells leaving the primary tumor and entering the blood flow immediately interact with platelets. Activated platelets contribute in different ways to cancer cell survival and proliferation, e.g. in formation of the earl...

Full description

Bibliographic Details
Main Authors: Jan Moritz Ponert, Svenja Schwarz, Reza Haschemi, Jens Müller, Bernd Pötzsch, Gerd Bendas, Martin Schlesinger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5773218?pdf=render
_version_ 1819091468651855872
author Jan Moritz Ponert
Svenja Schwarz
Reza Haschemi
Jens Müller
Bernd Pötzsch
Gerd Bendas
Martin Schlesinger
author_facet Jan Moritz Ponert
Svenja Schwarz
Reza Haschemi
Jens Müller
Bernd Pötzsch
Gerd Bendas
Martin Schlesinger
author_sort Jan Moritz Ponert
collection DOAJ
description Metastasis is responsible for the majority of cancer associated fatalities. Tumor cells leaving the primary tumor and entering the blood flow immediately interact with platelets. Activated platelets contribute in different ways to cancer cell survival and proliferation, e.g. in formation of the early metastatic niche by release of different growth factors and chemokines. Here we show that a direct interaction between platelets and MV3 melanoma or MCF7 breast cancer cells induces platelet activation and a VEGF release in citrated plasma that cannot be further elevated by the coagulation cascade and generated thrombin. In contrast, the release of platelet-derived chemokines CXCL5 and CXCL7 depends on both, a thrombin-mediated platelet activation and a direct interaction between tumor cells and platelets. Preincubation of platelets with therapeutic concentrations of unfractionated heparin reduces the tumor cell initiated VEGF release from platelets. In contrast, tumor cell induced CXCL5 and CXCL7 release from platelets was not impacted by heparin pretreatment in citrated plasma. In defibrinated, recalcified plasma, on the contrary, heparin is able to reduce CXCL5 and CXCL7 release from platelets by thrombin inhibition. Our data indicate that different chemokines and growth factors in diverse platelet granules are released in tightly regulated processes by various trigger mechanisms. We show for the first time that heparin is able to reduce the mediator release induced by different tumor cells both in a contact and coagulation dependent manner.
first_indexed 2024-12-21T22:40:12Z
format Article
id doaj.art-834b929a77ed4add9009b5a74b6f8117
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T22:40:12Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-834b929a77ed4add9009b5a74b6f81172022-12-21T18:47:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01131e019130310.1371/journal.pone.0191303The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.Jan Moritz PonertSvenja SchwarzReza HaschemiJens MüllerBernd PötzschGerd BendasMartin SchlesingerMetastasis is responsible for the majority of cancer associated fatalities. Tumor cells leaving the primary tumor and entering the blood flow immediately interact with platelets. Activated platelets contribute in different ways to cancer cell survival and proliferation, e.g. in formation of the early metastatic niche by release of different growth factors and chemokines. Here we show that a direct interaction between platelets and MV3 melanoma or MCF7 breast cancer cells induces platelet activation and a VEGF release in citrated plasma that cannot be further elevated by the coagulation cascade and generated thrombin. In contrast, the release of platelet-derived chemokines CXCL5 and CXCL7 depends on both, a thrombin-mediated platelet activation and a direct interaction between tumor cells and platelets. Preincubation of platelets with therapeutic concentrations of unfractionated heparin reduces the tumor cell initiated VEGF release from platelets. In contrast, tumor cell induced CXCL5 and CXCL7 release from platelets was not impacted by heparin pretreatment in citrated plasma. In defibrinated, recalcified plasma, on the contrary, heparin is able to reduce CXCL5 and CXCL7 release from platelets by thrombin inhibition. Our data indicate that different chemokines and growth factors in diverse platelet granules are released in tightly regulated processes by various trigger mechanisms. We show for the first time that heparin is able to reduce the mediator release induced by different tumor cells both in a contact and coagulation dependent manner.http://europepmc.org/articles/PMC5773218?pdf=render
spellingShingle Jan Moritz Ponert
Svenja Schwarz
Reza Haschemi
Jens Müller
Bernd Pötzsch
Gerd Bendas
Martin Schlesinger
The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
PLoS ONE
title The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
title_full The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
title_fullStr The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
title_full_unstemmed The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
title_short The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
title_sort mechanisms how heparin affects the tumor cell induced vegf and chemokine release from platelets to attenuate the early metastatic niche formation
url http://europepmc.org/articles/PMC5773218?pdf=render
work_keys_str_mv AT janmoritzponert themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT svenjaschwarz themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT rezahaschemi themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT jensmuller themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT berndpotzsch themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT gerdbendas themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT martinschlesinger themechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT janmoritzponert mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT svenjaschwarz mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT rezahaschemi mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT jensmuller mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT berndpotzsch mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT gerdbendas mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation
AT martinschlesinger mechanismshowheparinaffectsthetumorcellinducedvegfandchemokinereleasefromplateletstoattenuatetheearlymetastaticnicheformation